Mogadon (Nitrazepam)

Nitrazepam acts on the central nervous system to facilitate sleep and reduce anxiety, primarily through modulation of GABA‑A receptors.

• Severe insomnia: helps initiate and maintain sleep during short‑term therapy.
• Anxiety disorders (off‑label): may alleviate acute anxiety symptoms.
• Certain seizure disorders (off‑label): used as an adjunct to control seizures in specific cases.

• Nitrazepam binds to a specific site on the GABA‑A receptor complex, acting as a positive allosteric modulator. This enhances the inhibitory effect of GABA, increasing chloride ion influx and hyperpolarizing neuronal membranes, which results in sedative, anxiolytic, muscle‑relaxant, and anticonvulsant effects.

Nitrazepam may cause a range of adverse reactions that vary in frequency and severity.

Common Side Effects

• Drowsiness: feeling unusually sleepy during the day.
• Fatigue: reduced energy and motivation.
• Dizziness: sensation of light‑headedness or unsteadiness.
• Impaired coordination: difficulty with fine motor tasks.
• Memory impairment: short‑term recall problems.
• Headache: mild to moderate head pain.

Serious or Rare Side Effects

• Depression or suicidal thoughts: mood changes requiring immediate attention.
• Respiratory depression: slowed breathing, especially with other depressants.
• Severe skin reactions: rash, Stevens‑Johnson syndrome.
• Paradoxical agitation: increased anxiety or aggression.
• Dependence and withdrawal seizures: risk with prolonged use.
• Hepatic dysfunction: abnormal liver enzymes.

When prescribing Nitrazepam, clinicians should assess patient risk factors and monitor for adverse outcomes.

• Assess severity: confirm that insomnia is severe and warrants pharmacologic therapy.
• Evaluate mental health: screen for depression or suicidal ideation before initiating treatment.
• Avoid abrupt discontinuation: taper the dose to reduce withdrawal risk.
• Use caution in elderly: increased sensitivity to sedation and falls.
• Contraindicated in pregnancy: category D indicates potential fetal harm.
• Store at ambient temperature: keep in the original container, protect from moisture.

Nitrazepam can interact with other medications, altering its efficacy or safety profile.

Major Interactions (Avoid)

• Alcohol: additive CNS depression leading to profound sedation.
• Opioids: increased risk of respiratory depression and profound sedation.
• Other benzodiazepines: cumulative sedative effects and heightened dependence risk.
• Azole antifungals (e.g., ketoconazole): inhibit metabolism, raising nitrazepam levels.
• Macrolide antibiotics (e.g., erythromycin): may increase plasma concentrations.

Moderate Interactions (Monitor Closely)

• SSRIs (e.g., fluoxetine): may enhance sedative effects.
• Antihistamines: additive drowsiness.
• Antihypertensives: potential for orthostatic hypotension.
• Carbamazepine: enzyme induction may reduce nitrazepam efficacy.
• Cimetidine: may modestly increase nitrazepam levels.